Precision medicine promises to revolutionize healthcare by tailoring treatments to individual genetic profiles and clinical histories. However, realizing this promise requires integrating vast amounts of disconnected data like genomic sequencing and single-cell transcriptomics to Electronic Health Records (EHR) and real-world evidence (RWE). For many organizations, this data remains trapped in silos, preventing the holistic view needed for true precision.

At Elucidata, we bridge the gap between translational research and clinical application. Our platform, Polly, makes biomedical data AI-ready at scale, enabling the seamless integration of multi-modal datasets. We help R&D teams harmonize proprietary and public omics data with clinical metadata, creating a unified, high-quality data asset.

This "data-centric" foundation empowers scientists to uncover novel biomarkers, validate targets with greater confidence, and refine patient stratification strategies using advanced AI and Machine Learning models.

Meet our team at PMWC 2026 to see how we are helping leading biopharma and diagnostic companies turn complex biological data into precise therapeutic insights.

‍